# ANTHIM
> **BLA125509** · Biologics License Application · Sponsor: ELUSYS THERAPEUTICS INC · Approved 2016-03-18
## Drug
- **FDA Application Number:** BLA125509
- **Application type:** Biologics License Application
- **Brand name:** ANTHIM
- **Generic name:** OBILTOXAXIMAB
- **Active ingredients:** OBILTOXAXIMAB
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** ELUSYS THERAPEUTICS INC
- **Manufacturer:** Elusys Therapeutics, Inc.
- **First approval:** 2016-03-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125509)
---
*AI Analytics · CC0 1.0*